Inventor · disambiguated record
Michael Weinfeld
Also filed as: WEINFELD MICHAEL
6 granted patents·3 pending applications·14 citations·filing 1998–2022
75Inventor score
Top patents by PatentIndex Score
9 records- 0174US9115406B2Synthetic lethality in cancerWEINFELD MICHAEL·Filed 2011·Granted Aug 25, 2015·2 cites·6 claims
- 0272US9040551B2Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereofWEINFELD MICHAEL·Filed 2010·Granted May 26, 2015·2 cites·13 claims
- 0365US2022249710A1Bioreductively-activated compounds, their prodrugs, radiopharmaceuticals, the compositions, and their applications in multimodal theranostic management of hypoxia diseases including cancerUNIV ALBERTA·Filed 2022·Application pending·0 cites
- 0453US10087448B2Synthetic lethality in cancerUNIV ALBERTA·Filed 2015·Granted Oct 2, 2018·0 cites·9 claims
- 0547US2020276338A1Bioreductively-activated compounds, their prodrugs, radiopharmaceuticals, the compositions, and their applications in multimodal theranostic management of hypoxia diseases including cancerUNIV ALBERTA·Filed 2018·Application pending·0 cites
- 0644US2022306603A1Targeting dna repair in tumor cells via inhibition of ercc1-xpfUNIV ALBERTA·Filed 2020·Application pending·0 cites
- 0743US6132968AMethods for quantitating low level modifications of nucleotide sequencesUNIV ALBERTA·Filed 1998·Granted Oct 17, 2000·10 cites·24 claims
- 0842US9694073B2Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(ADP-ribose) polymerase and uses thereofUNIV ALBERTA·Filed 2015·Granted Jul 4, 2017·0 cites·21 claims
- 0937US11325905B2Imidopiperidine compounds as inhibitors of human polynucleotide kinase phosphataseUNIV ALBERTA·Filed 2018·Granted May 10, 2022·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →